Roivant Sciences Ltd.

Insider Reports History

Location
London
Signature
/s/ Keyur Parekh, as Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roivant Sciences Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Director, 10%+ Owner Common Stock, $0.0001 par value per share 113,317,007 $2,379,657,147 $21.00 12 Dec 2025 Direct
Arbutus Biopharma Corp 10%+ Owner Common shares, without par value 38,847,462 18 Oct 2021 Direct
Arbutus Biopharma Corp 10%+ Owner Series A participating convertible preferred shares 0 18 Oct 2021 Direct

Insider Reports Filed by Roivant Sciences Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMVT Immunovant, Inc. 12 Dec 2025 1 +$349,999,986 4 Director, 10%+ Owner 12 Dec 2025, 17:17
IMVT Immunovant, Inc. 13 Jan 2025 1 +$336,900,200 4 Director, 10%+ Owner 15 Jan 2025, 16:36
IMVT Immunovant, Inc. 02 Oct 2023 2 +$228,000,000 4 Director, 10%+ Owner 04 Oct 2023, 17:15
IMVT Immunovant, Inc. 06 Oct 2022 1 +$2,500,002 4 10%+ Owner 07 Oct 2022, 16:32
ABUS Arbutus Biopharma Corp 18 Oct 2021 2 $0 4 10%+ Owner 20 Oct 2021, 17:14
IMVT Immunovant, Inc. 02 Aug 2021 1 $0 4 10%+ Owner 02 Aug 2021, 21:46